儿童社区获得性肺炎病原菌及其疗效的影响因素

Pathogenic bacteria in children with community-acquired pneumonia and influencing factors for therapeutic efficacy

  • 摘要: 目的 探讨儿童社区获得性肺炎(CAP)病原菌与气道炎症因子及疗效的影响因素。方法 选取2019年6月-2021年9月河南大学淮河医院确诊的137例痰培养阳性CAP患儿,记录病原菌鉴定结果;根据患儿入院治疗7 d后临床疗效,分为有效组99例、无效组38例,比较两组患儿治疗前后气道炎症因子诱导痰中核因子-κB(NF-κB)、半乳凝素3(Gal-3)、甲壳质酶蛋白40(YKL-40)水平,分析气道炎症因子与病情程度临床肺部感染评分(CPIS)、小儿危重病例评分(PCIS)的相关性,探究影响疗效的风险因素及气道炎症因子对疗效的预测价值。结果 137例CAP患儿共培养分离细菌158株,其中革兰阴性菌92株占58.23%、革兰阳性菌66株占41.77%,以肺炎链球菌、流感嗜血杆菌、肺炎克雷伯菌为主;治疗前后,有效组NF-κB、Gal-3、YKL-40均低于无效组(P<0.05),且NF-κB、Gal-3、YKL-40治疗前后下降幅度大于无效组(P<0.05);多重细菌感染、CPIS评分、PCIS评分是CAP患儿抗菌疗效的影响因素(P<0.05);NF-κB、Gal-3、YKL-40预测CAP患儿抗菌治疗无效的受试者工作特征(ROC)曲线下面积分别为0.760、0.716、0.767。结论 肺炎链球菌、流感嗜血杆菌、肺炎克雷伯菌是小儿CAP主要致病菌,多重细菌混合感染可影响患儿抗菌药物治疗效果;NF-κB、Gal-3、YKL-40可作为早期疗效预测指标。

     

    Abstract: OBJECTIVE To investigate the the pathogenic bacteria and airway inflammatory factors in children with community-acquired pneumonia (CAP) and the influencing factors of therapeutic efficacy. METHODS Totally 137 children with CAP and positive sputum culture diagnosed in Huaihe Hospital of Henan University were selected between Jun. 2019 and Sep. 2021, and the results of pathogen identification were recorded. According to the clinical efficacy of children after 7 days of treatment, they were divided into 99 cases of effective group and 38 cases of ineffective group. The levels of airway inflammatory factors nuclear factor-κB (NF-κB), galectin 3 (Gal-3) and chitinase-3-like-1 protein (YKL-40) in induced sputum were compared between the two groups before and after treatment. The correlation between airway inflammatory factors and disease severity Clinical Pulmonary Infection Score (CPIS), Pediatric Critical Illness Score (PCIS) was analyzed, and the risk factors affecting the efficacy and the predictive value of airway inflammatory factors on the efficacy were explored. RESULTS A total of 158 strains of pathogenic bacteria were isolated from 137 children with CAP, of which 92 strains of Gram-negative bacteria accounted for 58.23%, and 66 strains of Gram-positive bacteria accounted for 41.77%. The main pathogenic bacteria were Streptococcus pneumoniae, Haemophilus influenzae and Klebsiella pneumoniae. Before and after treatment, the NF-κB, Gal-3 and YKL-40 in the effective group were lower than those in the ineffective group (P<0.05), and the decreases of NF-κB, Gal-3 and YKL-40 before and after treatment were greater than those in ineffective group (P<0.05). Multiple bacterial infections, CPIS score and PCIS score were the risk factors affecting the antimicrobial efficacy of children with CAP (P<0.05). The areas under the receiver operating characteristic (ROC) curve of NF-κB, Gal-3 and YKL-40 in predicting the ineffectiveness of antibacterial therapy in children with CAP was 0.760, 0.716 and 0.767, respectively. CONCLUSION Streptococcus pneumoniae, Haemophilus influenzae and Klebsiella pneumoniae were the main pathogenic bacteria of CAP in children. Multiple bacterial mixed infections could affect the therapeutic efficacy of antibacterial drugs in children. In addition, NF-κB, Gal-3 and YKL-40 might be used as early predictors of efficacy.

     

/

返回文章
返回